Moulay A. Alaoui‐Jamali

Jewish General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Moulay A. Alaoui‑Jamali is a leading figure in cancer biology and precision oncology, with a particular focus on head and neck cancers and the molecular mechanisms driving tumor progression and drug resistance. His work has significantly advanced the understanding of how genetic and epigenetic alterations, such as those involving the MET oncogene and DNA repair pathways, influence cancer aggressiveness and treatment outcomes. Among his most impactful contributions is the exploration of neoadjuvant therapy and de‑escalation strategies in HPV‑positive head and neck cancer, a paradigm‑shifting approach that aims to reduce treatment toxicity while maintaining efficacy. This work, published in 2024, has already garnered early attention with 5 citations, reflecting its timely relevance in the field. Dr. Alaoui‑Jamali’s research has been widely recognized, with his most cited papers collectively amassing hundreds of citations, underscoring his influence on both basic science and clinical translation. His dedication to bridging laboratory discoveries with patient‑centered care makes him a pivotal voice in the ongoing effort to personalize cancer therapy and improve survival outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago